- Stock: In Stock
- Brand: Beximco Pharmaceutical
- Product ID: Acetylcysteine
Available Options
100% Secure Payment
bKash | Nagad | Cards via SSLCommerz | COD
Monthly Medicines Available | Free Delivery on Eligible Orders
Mucomist 600mg Respirator Solution — Acetylcysteine 600mg | Beximco Pharmaceuticals
| Generic Name | Acetylcysteine (N-Acetylcysteine / NAC) 600 mg per vial |
| Dosage Form | Respirator Solution for Nebulization |
| Manufacturer | Beximco Pharmaceuticals Ltd. |
| Therapeutic Class | Mucolytic Agent |
| Route of Administration | Inhalation via nebulizer |
| Availability | In Stock — Available Online |
Overview
Mucomist 600mg Respirator Solution contains Acetylcysteine (NAC) 600 mg in a sterile solution formulated for nebulization. Acetylcysteine is the gold-standard mucolytic agent, breaking down the disulfide bonds in mucus glycoproteins to reduce viscosity and facilitate expectoration. When administered via nebulizer, it acts directly on airway secretions, making it particularly effective for patients with thick, tenacious mucus that is difficult to clear — a common and debilitating problem in COPD, bronchiectasis, cystic fibrosis, and acute lower respiratory tract infections.
Mechanism of Action
Acetylcysteine acts as a free thiol donor, cleaving the disulfide bonds in the mucus polymer network. This reduces mucus viscosity and elasticity, converting thick gel-like secretions into a thinner, more mobile liquid that can be cleared by coughing or mucociliary transport. Additionally, NAC's free thiol group is a potent antioxidant — it replenishes glutathione stores and scavenges reactive oxygen species (ROS) produced by inflammatory cells in the airways, providing anti-inflammatory benefits beyond simple mucus thinning.
Indications
- COPD with Mucus Hypersecretion — reduces exacerbation frequency; improves mucus clearance in chronic bronchitis
- Acute Bronchitis — particularly when productive cough with thick yellow-green mucus is present
- Bronchiectasis — daily nebulization to maintain airway clearance
- Cystic Fibrosis — adjunct to physiotherapy for mucus clearance
- Post-operative Pulmonary Hygiene — reduces atelectasis risk in ventilated/sedated patients
- Pneumonia with Thick Secretions — aids expectoration to speed resolution
Dosage & Administration
| Patient Group | Dose | Frequency | Dilution |
|---|---|---|---|
| Adults | 300–600 mg (1 vial) | 2–3 times daily | Dilute with normal saline (0.9% NaCl) to 3–4 mL total volume |
| Children (6–12 yr) | 150–300 mg | 2–3 times daily | Dilute as directed by physician |
| Children (<6 yr) | Under specialist guidance only | — | — |
Nebulizer tips: Use a jet nebulizer. Avoid ultrasonic nebulizers if possible (may degrade the solution). Nebulize in upright position. After nebulization, encourage deep breathing and coughing exercises to expectorate loosened mucus. Clean nebulizer after each use.
Important: Do NOT mix Mucomist solution with antibiotics or other medications in the same nebulizer chamber — chemical incompatibility may inactivate both medicines.
Special Populations
- Diabetic patients: No direct blood glucose effect from inhaled acetylcysteine. Safe to use in diabetics with respiratory comorbidities (COPD, bronchitis).
- Elderly: Effective and well-tolerated; ensure patient can use nebulizer correctly or has carer assistance.
- Asthma: Use with caution — inhaled NAC may trigger bronchospasm in some asthmatic patients. Pre-treat with bronchodilator (salbutamol) before nebulization. Monitor closely during first use.
- Pregnancy/Lactation: Use only if clearly needed; insufficient clinical data — consult physician.
Drug Interactions
| Drug/Agent | Interaction |
|---|---|
| Antibiotics (in nebulizer) | Do not mix — NAC inactivates many antibiotics in solution |
| Activated Charcoal (oral) | Adsorbs NAC — reduces oral antidote efficacy (relevant for overdose treatment) |
| Nitroglycerin | NAC may potentiate vasodilatory effect — potential hypotension |
| Antitussives (cough suppressants) | Do not combine — suppressing cough impairs expectoration of loosened mucus |
Side Effects
- Common: Mild nausea (from swallowed solution residue), sulphurous odour during nebulization
- Respiratory: Bronchospasm (rare — monitor asthmatics closely)
- Skin: Urticaria, pruritus (rare hypersensitivity)
- Serious (rare): Anaphylaxis — discontinue and seek immediate medical attention
Storage
- Store below 25°C, protected from light. Once opened, use immediately — do not store opened vials. Keep out of reach of children.
FAQ
Q1: Can Mucomist Respirator Solution be used in a home nebulizer?
Yes — Mucomist 600mg is designed for outpatient home use with a standard jet nebulizer. Dilute with the prescribed amount of normal saline (0.9% NaCl), nebulize in upright position, and perform deep breathing and coughing exercises after the session to clear the loosened mucus. Clean the nebulizer thoroughly after each use.
Q2: Why does the nebulized solution smell bad?
Acetylcysteine has a characteristic sulphurous (egg-like) odour due to its thiol (-SH) group. This is entirely normal and does not indicate spoilage or degradation. The smell is harmless. Some patients find the odour reduces with continued use.
Q3: Can I use Mucomist with my antibiotic nebulizer solution?
No — do not mix Mucomist with antibiotics or other drugs in the same nebulizer cup. Acetylcysteine is chemically incompatible with many antibiotics. If your physician prescribes both, nebulize them separately with a thorough rinse of the nebulizer between uses.
Q4: Is Mucomist Respirator Solution the same as Mucomist DT (dispersible tablet)?
Both contain Acetylcysteine 600 mg, but the routes of administration differ. Mucomist Respirator Solution is for inhalation via nebulizer — it acts directly on airway secretions. Mucomist DT is a dispersible tablet taken orally — absorbed systemically and reaches the airways through the bloodstream. Your physician will prescribe the appropriate form based on your condition and severity.
Q5: Is this safe for patients with diabetes?
Yes. Inhaled acetylcysteine has no direct effect on blood glucose. Mucomist Respirator Solution is safe for diabetic patients with respiratory conditions such as COPD or bronchitis who require mucolytic nebulization therapy.
Medical Disclaimer: Educational information only. Nebulization therapy should be initiated and supervised by a licensed physician or respiratory therapist.
